The country of origin of particle-enhanced turbidimetric immunoassay components
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- Hence, the country of origin of the R1 of both the fPELA turbo Reagent and fCAL turbo Reagent will be Norway.
- Hence, the country of origin of the R2 of both the fPELA turbo Reagent and fCAL turbo Reagent will be Norway.
- As such, the country of origin of the fPELA turbo Reagent will be Norway.
Ruling text
In your letter dated June 17, 2026, on behalf of BÜHLMANN Laboratories AG, you requested a country of origin determination ruling. The products under consideration are the fPELA turbo Reagent, the fCAL turbo Reagent, fCAL turbo Calibrator, and the fCAL turbo Control, which are imported and sold separately. Additional information was provided via email dated June 29, 2026.
The fPELA turbo Reagent (also referred to as “B-KPELA-RSET”) is a reagent kit composed of two types of vials, R1 (reaction buffer) and R2 (immunoparticles). R1 consists of a base buffer, proteins (serving as blockers to reduce unintended binding of the R2 reagent to non-analytes), a surfactant, a conserving agent with anti-microbial properties, and deionized water.
R2 contains polystyrene beads coated with antibodies (also known as conjugated immune-particles), a base buffer (different from that in R1), a surfactant, a conserving agent with anti-microbial properties, and deionized water. In Norway, antibodies originating from Germany are covalently coupled to US-origin polystyrene beads to produce conjugated immune-particles, a process involving a chemical reaction. The base buffers, blocking proteins, and deionized water are manufactured in Norway.
The surfactant is a product of Switzerland and the conserving agent is a product of Germany. The ingredients for R1 and R2 are fully mixed in Norway and then filled into vials; this mixing does not involve a chemical reaction. After quality control testing, the products are shipped to Switzerland. In Switzerland, R1 and R2 undergo inspection and additional quality control testing, and are then packaged into the fPELA turbo Reagent kit.
The fCAL turbo Reagent (also referred to as “B-KCAL-RSET”) is a reagent kit composed of two types of vials, R1 (reaction buffer) and R2 (immunoparticles). The R1 and R2 vials contain the same ingredients as those in the fPELA turbo Reagent, except that R1 in the fCAL turbo Reagent uses a different base buffer. The manufacturing processes performed in Norway and Switzerland are the same as for the fPELA turbo Reagent, except that the antibodies are sourced from Norway.
The fCAL turbo Calibrator (also referred to as “B-KCAL-CASET”) is a calibrator kit composed of six vials containing human calprotectin (the analyte) at different concentrations. Each vial consists of human calprotectin, a base buffer, a surfactant, two conserving agents, a blocker (to reduce unintended binding of the R2 reagent to non-analytes), and deionized water. The base buffer, surfactant, one of the conserving agents, and blocker are made in Switzerland, while the other conserving agent is made in Germany.
The human calprotectin is produced in Norway, where it is added to the base buffer in six specified concentrations to form six analyte mixtures. This mixing occurs in Norway and does not result in a chemical reaction. The bulk analyte mixtures are then shipped to Switzerland. In Switzerland, the analyte mixtures at different concentrations are mixed with the remaining ingredients; this mixing also does not involve a chemical reaction.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N362413).